Area of research
Reproductive Medicine · Cancer Research
Research interest
Research interests include Medicine, Internal medicine, Oncology, Ovarian cancer, Bevacizumab, and Clinical endpoint.
A genotype-first approach identifies high incidence of NF1 pathogenic variants with distinct disease associations
Surgical and Blood-Based Minimal Residual Disease in Patients with Ovarian Cancer after First-line Therapy: Clinical Outcomes and Translational Opportunities
Circulating tumor DNA monitoring in ovarian cancer patients receiving PARPi maintenance therapy: Can we further personalize treatment?
Association of Tumor-informed Circulating Tumor DNA Detectability Before and After Radical Cystectomy with Disease-free Survival in Patients with Bladder Cancer
Longitudinal Testing of Circulating Tumor DNA in Patients With Metastatic Renal Cell Carcinoma
Niraparib and dostarlimab for the treatment of recurrent platinum-resistant ovarian cancer: results of a Phase II study (MOONSTONE/GOG-3032)
DKK1 is a predictive biomarker for response to DKN-01: Results of a phase 2 basket study in women with recurrent endometrial carcinoma
Circulating tumor DNA monitoring for early recurrence detection in epithelial ovarian cancer
Molecular profiles of endometrial cancer tumors among Black patients
Genomic profiling in low grade serous ovarian cancer: Identification of novel markers for disease diagnosis and therapy
MOONSTONE/GOG-3032: Interim analysis of a phase 2 study of niraparib + dostarlimab in patients (pts) with platinum-resistant ovarian cancer (PROC).
Neratinib in patients with HER2-mutant, metastatic cervical cancer: Findings from the phase 2 SUMMIT basket trial
NCCN Guidelines Insights: Ovarian Cancer, Version 1.2019
Comparison of bevacizumab alone or with chemotherapy in recurrent ovarian cancer patients